Encompass Health CFO Douglas E. Coltharp sold 18,869 shares for about $2.4 million on August 10, according to an SEC filing. The sale came the same day as a much larger sale by CEO Mark Tarr, who cut about 39% of his direct stake, while Coltharp's trim was far smaller and left him with 241,000 shares worth roughly $30.4 million. Encompass Health recently reported revenue grew about 10% to $1.6 billion, raised full-year guidance for the second time this year, and boosted its dividend and buyback authorization to $1 billion. The stock jumped to near a 52-week high on those results.
Encompass Health CorpCompany raised guidance, boosted dividend and buyback, and stock jumped to near 52-week high.
